BIOTECHNOLOGY VALUE FUND L P - 31 Dec 2025 SCHEDULE 13G/A Report for Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share (CGEM)

Filing Manager
BIOTECHNOLOGY VALUE FUND L P
Reporting Manager
BVF PARTNERS L P/IL
Security
Cullinan Therapeutics, Inc. Common Stock, par value $0.0001 per share
Symbol
CGEM
Shares outstanding
59,244,054 shares
Disclosed Ownership
5,918,481 shares
Ownership
10%
Form type
SCHEDULE 13G/A
Filing time
17 Feb 2026, 16:10:11 UTC
Date of event
31 Dec 2025
SEC
View on sec.gov

Reporting Managers (10)

Name Ownership Shares Owned sole voting power shared voting power Signature Title CIK
BIOTECHNOLOGY VALUE FUND L P 5.6% 3,302,376 0 3,302,376 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF I GP LLC 5.6% 3,302,376 0 3,302,376 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BIOTECHNOLOGY VALUE FUND II LP 3.8% 2,271,662 0 2,271,662 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF II GP LLC 3.8% 2,271,662 0 2,271,662 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
Biotechnology Value Trading Fund OS LP 0.4% 224,641 0 224,641 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF Partners OS Ltd. 0.4% 224,641 0 224,641 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF GP HOLDINGS LLC 9.4% 5,574,038 0 5,574,038 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF PARTNERS L P/IL 10% 5,918,481 0 5,918,481 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
BVF INC/IL 10% 5,918,481 0 5,918,481 /s/ Mark N. Lampert Mark N. Lampert, Authorized Signatory
LAMPERT MARK N 10% 5,918,481 0 5,918,481 /s/ Mark N. Lampert Mark N. Lampert